China Resources Medical Tightens Audit Committee Governance Framework

China Resources Medical Holdings Co ( (HK:1515) ) has shared an announcement.

China Resources Medical Holdings has updated and re-adopted the terms of reference for its audit committee, refining its membership structure, meeting procedures and powers to align with Hong Kong Listing Rules and the Corporate Governance Code. The revised framework reinforces that the committee must be composed mainly of independent non-executive directors, meet at least twice a year with both internal and external auditors, and is empowered to investigate relevant matters, obtain independent professional advice and report significant fraud, risk management failures or compliance issues to the board, underscoring a stronger emphasis on transparency, internal control and investor protection.

The most recent analyst rating on (HK:1515) stock is a Sell with a HK$3.00 price target. To see the full list of analyst forecasts on China Resources Medical Holdings Co stock, see the HK:1515 Stock Forecast page.

More about China Resources Medical Holdings Co

China Resources Medical Holdings Company Limited is a healthcare services group incorporated in the Cayman Islands and listed in Hong Kong, operating hospitals and related medical businesses through its subsidiaries. The group functions under Hong Kong’s Listing Rules and Corporate Governance Code, indicating a focus on regulated capital markets and adherence to international corporate governance standards.

Average Trading Volume: 5,796,530

Current Market Cap: HK$4.23B

For detailed information about 1515 stock, go to TipRanks’ Stock Analysis page.